🚀 4000+ Interns Trained  •  200+ Events Conducted  •  115+ Startups Incubated  •  100+ Mentors Onboarded  •  600Cr+ Combined Valuation  •  15,000+ Beneficiaries🚀 4000+ Interns Trained  •  200+ Events Conducted  •  115+ Startups Incubated  •  100+ Mentors Onboarded  •  600Cr+ Combined Valuation  •  15,000+ Beneficiaries🚀 4000+ Interns Trained  •  200+ Events Conducted  •  115+ Startups Incubated  •  100+ Mentors Onboarded  •  600Cr+ Combined Valuation  •  15,000+ Beneficiaries🚀 4000+ Interns Trained  •  200+ Events Conducted  •  115+ Startups Incubated  •  100+ Mentors Onboarded  •  600Cr+ Combined Valuation  •  15,000+ Beneficiaries
TBI-GEU × India Accelerator · 22-Week Cohort

From Research Excellence to MedTech Impact.

A high-velocity accelerator for startups building medical devices, diagnostics, and healthcare technology for India.

Hospital Clinical Trials & Pilots
CDSCO Classification & ISO 13485
TBI-GEU Deep-Tech Prototyping Labs
Demo Day: April 2027
22 Weeks Acceleration Curated Startup Cohort No Upfront Equity or Participation Fee Startups Keep Their IP
22 weeks
Intensive Roadmap
From bench prototype to pilot-ready validation
Curated
Startup Cohort
Personalized 1:1 attention & clinical trial support
1:1 Mentors
Clinical & Regulatory
Veteran medical directors, clinicians and CDSCO experts
April 2027
National Demo Day
Pitch live to 50+ healthcare VCs and angel networks
ABOUT THE PROGRAMME

Bridging the gap between laboratory research and clinical adoption.

Most Indian MedTech startups stall not on scientific engineering, but on the complex hurdles that follow: clinical trial access, CDSCO device classification, ISO 13485 audits, hospital procurement inertia, and seed funding. This programme unites three formidable forces to systematically dismantle those barriers.

Pillar 01 · Commercial Execution

India Accelerator

India's premier seed accelerator & GAN partner with 250+ startups. IA injects market access, pricing discipline, corporate hospital tie-ups, regulatory advisory, and a dedicated healthcare angel syndicate.

  • 14+ HealthTech portfolio investments
  • Leaders from Medanta, Fortis & NATHEALTH
Pillar 02 · Deep-Tech Infrastructure

TBI-GEU

DST-supported deep-tech incubation ecosystem with state-of-the-art cleanrooms, 3D additive manufacturing, CNC machining, medical electronics testing benches, and faculty clinician partnerships.

  • Full prototyping and test lab access
  • Hospital ethics committee clearance linkages
Pillar 03 · Defensible Innovation

The Startup Cohort

A curated startup cohort of early-stage founders with validated lab prototypes (TRL 4+), patents, and proprietary hardware/AI architectures ready to transition from benchwork to hospital clinical adoption.

  • 1:1 individualized roadmap and sprint goals
  • Zero cohort fee and no mandatory equity
WHY MEDTECH · INDIA'S MOMENT

Bench to Bedside: Building for Bharat and the World.

India is at an inflection point. Domestic healthcare expenditure is surging, government PLI schemes and MedTech parks are providing manufacturing tailwinds, and over 70% of medical devices remain imported.

$30–50B
Projected Indian MedTech market by 2030, surging from ~$14B today
10–12%
Consistent annual CAGR across medical equipment, diagnostics, and consumables
70–80%
Medical devices currently imported — massive indigenous Make-in-India opportunity
1.4 Billion
Population driving unprecedented demand for decentralized, affordable care
Indian Healthcare Venture Landscape
1,259+
HealthTech & MedTech startups actively pioneering solutions across India
348
Startups successfully backed with institutional seed and early-stage capital
$1.06B
Total risk capital deployed into early and growth-stage Indian HealthTech
58
High-growth healthcare ventures that have crossed Series A and expansion rounds
WHAT YOU GET

The infrastructure, capital and network your startup needs.

Every component of this accelerator is tailored specifically to medical technology, clinical pathways, and hardware development timelines.

Benefit 01

Research labs, technical infrastructure and testing facilities

Full access to Graphic Era's high-spec prototyping labs, cleanroom facilities, 3D additive manufacturing, CNC machining, and biomedical electronics testing benches.

Benefit 02

Collaborative R&D and technology validation

Structured R&D collaboration with university faculty, clinical researchers, and hospital networks for in-depth laboratory testing and clinical proof-of-concept validation.

Benefit 03

Technical feedback and product development support

Hands-on engineering teardowns, design-for-manufacturing (DFM), embedded hardware optimization, and device safety compliance guidance from seasoned biomedical engineers.

Benefit 04

Mentors, investors and subject matter experts

Direct 1:1 mentorship from veteran healthcare founders, hospital clinical directors, former CDSCO technical panelists, and life-sciences venture capital partners.

Benefit 05

Business model refinement, pitch preparation and market access support

Institutional hospital procurement strategies, unit economics modeling, pilot design, and commercial distribution pipelines through India Accelerator.

Benefit 06

Investor readiness support, then Demo Day in front of investors and industry experts

Battle-tested data room and pitch deck coaching culminating in a national Demo Day in April 2027 before 50+ leading healthcare angels, syndicates, and seed funds.

Benefit 07

Internship and talent access from GEU students

Direct recruitment pipelines to hire high-caliber student interns and research fellows across biomedical engineering, electronics, computer science, and healthcare management.

No upfront equity or participation fee
Startups keep their IP
Apply to Cohort
SECTOR FOCUS

Six frontiers of medical innovation.

We back founders building defensible technologies that improve clinical outcomes, reduce care delivery costs, or widen geographic access across Tier-2/3 India and global emerging markets.

Diagnostics

Point-of-Care Diagnostics

Rapid bedside diagnostics, automated screening kits, microfluidics, biomarker detection, and portable testing devices engineered for decentralized clinical and primary care settings.

Imaging & Radiology

Medical Imaging

Portable ultrasound, AI-enhanced radiology scanners, compact handheld optical devices, and digital pathology tools delivering high-resolution diagnostics at accessible costs.

Critical Care

Patient Monitoring

Continuous ICU and bedside vitals tracking, multiparameter patient monitors, automated clinical alerting systems, and wireless telemetry reducing healthcare provider burden.

Surgical Tech

Surgical Devices

Minimally invasive instruments, precision electrosurgical tools, targeted ablation systems, and endoscopic hardware delivering higher surgical accuracy and safety.

Implants & Rehab

Implants and Prosthetics

Patient-specific 3D-printed orthopedic and dental implants, biocompatible surface coatings, bioresorbable fixation hardware, and active motorized prosthetics.

Wearables & Telehealth

Wearable Health Tech

Continuous biometric telemetry wearables, non-invasive home health tracking sensors, early chronic disease detection patches, and connected preventive health devices.

WHO CAN APPLY

Eligibility criteria for the 2027 cohort.

We focus on deep-tech medical innovators who have crossed the early exploratory phase and are ready to tackle commercialization, validation, and regulatory milestones.

Criteria 01 · Stage

MVP or Early Traction

Early-stage startups with a functional minimum viable product (MVP), benchtop prototype, or early clinical and market traction (TRL 4+).

Laboratory Proof or Alpha Unit
Criteria 02 · Legal Status

Registered Indian Entity

Pvt. Ltd. registered in India, not older than 10 years, with annual turnover not exceeding ₹100 crore (or research teams committed to incorporating upon selection).

DPIIT & Indian Entity Compliant
Criteria 03 · Sector

MedTech Aligned

Startups building medical devices, diagnostics, implants, assistive technology, ICU/hospital equipment, or software with an explicit medical purpose.

Aligned with 6 Focus Areas
Quick Self-Assessment

Am I eligible for this cohort?

Question 1 · Stage

Do you have a working prototype, benchtop MVP, or early market/clinical traction?

Question 2 · Legal Status

Is your venture an Indian entity (<10 years, turnover <₹100 Cr) or committed to incorporating upon selection?

Question 3 · Sector Focus

Is your solution in MedTech (devices, diagnostics, equipment, implants, or clinical medical software)?

Answer all 3 questions above to check your qualification status instantly.

PROGRAMME STRUCTURE

A 22-week roadmap from prototype to commercial pilot.

Clear timelines and structured deliverables ensure every participating founder exits with clinical validation protocols, CDSCO regulatory clarity, and investor readiness.

Phase 01Active
20 Nov 2026
Applications Open

National call for applications opens across research universities, incubators, hospital innovation cells, and healthcare founder networks.

Apply Now
Phase 02
December 2026
Applications Close

Evaluation committee conducts technical screening, shortlists top 25 teams for pitch juries, and finalizes the curated startup cohort.

Screening & Selection
Phase 03
10 Jan 2027
Cohort Kickoff

22-week acceleration launches: clinical trial design, product teardowns, CDSCO roadmap drafting, and 1:1 mentor assignments.

Hybrid Sprints + Labs
Phase 04 · Finale
April 2027
National Demo Day

Startups pitch live to healthcare seed VCs, family offices, angel syndicates, and hospital network procurement leaders.

Investor Syndication

Cohort Specifications & Key Information

Cohort Size
Curated Startup Cohort
Strictly curated for 1:1 guidance
Duration
22 Weeks
Jan 2027 to May 2027
Format
Hybrid Model
Virtual sprints + Dehradun labs
Cost To Founders
Zero Upfront Cost
No mandatory equity to apply
MENTOR NETWORK

Learn from leaders who have built, scaled and funded MedTech.

Our mentor network brings together leaders from NATHEALTH, Fortis, Suburban Diagnostics, Eight Roads, Medicom, and premier medical institutes.

AB
NATHEALTH & Philips

Anjan Bose

Former Founding Secretary General, NATHEALTH

Former President, Philips Healthcare and Consumer Lifestyle.

MB
Medicom Healthcare

Mukul Bagga

MD, Medicom Healthcare India

Previously Novartis, Quest Diagnostics, J&J and Ranbaxy.

VS
Clinical Innovation

Dr. Virender Sangwan

Director, Innovation, Dr. Shroff's Charity Eye Hospital

Distinguished clinical innovator and researcher. Previously L V Prasad Eye Institute.

DN
Pharma & Therapeutics

Deepak Naik

MD, Health N'U' Therapeutics

Previously Ranbaxy, Eisai Pharmaceuticals and Wockhardt.

SA
Diagnostics Founder

Dr. Sanjay Arora

Founder, Suburban Diagnostics

Pioneering clinical diagnostics entrepreneur and healthcare leader across India.

VA
Cardiometrics Tech

Vijayasimha Ajarananda

CEO, Audicor Cardiometrics

Expertise in cardiac diagnostics, physiological monitoring devices, and biomedical engineering.

SD
Public Health

Dr. Shikha Dhawan

Director, Programs, SHARE India

Public health specialist spearheading multi-institutional healthcare implementation programs.

DK
Venture Capital

Deepak Kanvinde

Venture Partner, Eight Roads

Venture investor with extensive experience in scaling deep-tech healthcare and life-sciences.

NR
Advanced R&I

Dr. Nita Roy

Consultant, Advanced Research R&I, L'Oreal India

Specialist in applied biotechnology, biomaterials research, and advanced formulation R&D.

RB
Clinical Specialist

Dr. Rahul Bhargava

Director and Head, Hematology and Stem Cell Transplant

Fortis Healthcare. Pioneer in clinical stem cell protocols and hospital healthcare innovation.

MW
Digital Health

Mark Waechter

Chief Evangelist, Future4Health

International digital health visionary, ecosystem strategist, and venture mentor.

VM
Hospital IT & Clinical

Vikas Malhotra

Director-Professor and Head, Chairman IT

Dr. Baba Saheb Ambedkar Medical College and Hospital. Leader in clinical IT and medical infrastructure.

PROGRAMME OUTCOMES

Clear milestones. Not just classroom lectures.

Every sprint is anchored around tangible deliverables that de-risk your technology, satisfy regulatory bodies, and prepare your startup for institutional seed rounds.

MILESTONE 01

Clinical Trial Protocol Ready

Verified ethical committee submission documentation, clinical trial registry protocol, and identified hospital pilot partners.

MILESTONE 02

CDSCO Regulatory Dossier

Device classification mapped, essential principles checklist completed, and testing laboratory schedule locked.

MILESTONE 03

Production BOM & Design Freeze

Industrial design freeze, production-grade Bill of Materials (BOM), and certified contract manufacturer pipeline in place.

MILESTONE 04

ABDM & Digital Interoperability

Architecture aligned with Ayushman Bharat Digital Mission (ABDM) standards for patient health records and EHR connectivity.

MILESTONE 05

Commercial Financial Model

Validated hospital capex/opex unit economics, insurance/reimbursement roadmap, and institutional pricing structure.

MILESTONE 06

Investor-Grade Demo Pitch

Battle-tested 5-minute pitch deck, data room, and cap-table ready for term sheet negotiations on Demo Day.

National Finale

Demo Day · April 2027

Pitch live to over 50 healthcare-focused angel investors, seed venture capital funds, corporate venture arms, and hospital procurement directors actively seeking commercial pilots and investment opportunities.

Apply NowApplications close December 2026
HAVE QUESTIONS?

Frequently Asked Questions

Everything you need to know about eligibility, program commitments, equity, funding, and IP ownership.

The focus is MedTech: devices, diagnostics, implants, equipment and software with a medical purpose. See the focus areas above.
ORGANISERS & ECOSYSTEM

Two powerhouses united for Indian MedTech.

Combining academic research excellence and hospital linkages with commercial acceleration rigor and venture capital access.

Host Institution

TBI-GEU

Technology Business Incubator (TBI) at Graphic Era (Deemed to be University), Dehradun, is supported by DST, Govt. of India. TBI-GEU nurtures deep-tech, electronics, AI, and healthcare innovations with state-of-the-art cleanrooms, prototyping labs, clinical trial hospital tie-ups, and pre-seed funding.

DST Recognized100+ Startups SupportedPrototyping Labs
Accelerator Partner

India Accelerator

India Accelerator is the country's premier seed accelerator, partnered with the Global Accelerator Network (GAN). With 250+ portfolio companies and 14+ dedicated healthcare investments across maternal care, genomics, and diagnostics, IA brings commercial mentorship from leaders at Medanta, Fortis, and NATHEALTH.

GAN Partner250+ Startups14+ HealthTech Portfolio
India Accelerator Track Record By The Numbers
250+
Startups Accelerated
$150M+
Follow-On Capital
120+
Global Mentors
50+
Hospital & Corp Partners
Applications open 20 November 2026

Applications Close December 2026

Cohort launch 10 January 2027No upfront equity or feeStartups keep their IP
Scan or click to apply for MedTech Accelerator
Scan QR with your phone
Quick direct application on Google Form
Apply Now

Whatever you are thinking, think bigger. Let's talk.

Background